Acuta Capital Partners’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-140,030
| Closed | -$1.89M | – | 43 |
|
|
2022
Q1 | $1.89M | Sell |
140,030
-170,000
| -55% | -$2.29M | 0.88% | 29 |
|
|
2021
Q4 | $4.04M | Buy |
310,030
+12,668
| +4% | +$165K | 1.7% | 21 |
|
|
2021
Q3 | $2.79M | Sell |
297,362
-129,698
| -30% | -$1.22M | 0.98% | 26 |
|
|
2021
Q2 | $4.37M | Buy |
427,060
+27,060
| +7% | +$277K | 1.75% | 17 |
|
|
2021
Q1 | $7.36M | Buy |
400,000
+7,000
| +2% | +$129K | 2.65% | 15 |
|
|
2020
Q4 | $13.5M | Buy |
393,000
+30,500
| +8% | +$1.04M | 3.66% | 8 |
|
|
2020
Q3 | $6.69M | Buy |
+362,500
| New | +$6.69M | 1.82% | 19 |
|